A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights
![](https://scriptworksrx.com/wp-content/uploads/2023/09/ldn-low-dose-naltrexone-research-compounding-1024x536.jpg)
Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.